Brentuximab vedotin and bendamustine as first-line treatment of Hodgkin lymphoma in the elderly (HALO Trial).
暂无分享,去创建一个
A. Rossi | R. Schiappa | A. Gallamini | E. Chamorey | S. Viviani | A. Thyss | F. Bijou | C. Patti | M. Cantonetti | D. Rapezzi | L. Gastaud | C. Debaigt | B. Thamphya | C. Borel | J. Colella | Lauriane Filliatre